Locally Recurrent Breast Cancer
4 clinical trials · Condition
◉ Watch Locally Recurrent Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer (NCT03786094) | Spexis AG | 2019-05-30 |
| Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer (NCT02064829) | Sorrento Therapeutics, Inc. | 2014-03-01 |
| The BEACON Study (Breast Cancer Outcomes With NKTR-102) (NCT01492101) | Nektar Therapeutics | 2011-12-01 |
Track Locally Recurrent Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.